Vir Biotechnology Inc.
NYSE: VIR
$33.14
-$0.86 (-2.5%)
Closing price January 20, 2022
Tuesday’s top analyst upgrades and downgrades included Bilibili, Carvana, Crocs, GameStop, Goldman Sachs, Nike, Sarepta Therapeutics, Vir Biotechnology and Weber.
23 days ago
Last Updated: 22 days ago
Monday’s top analyst upgrades and downgrades included Bionano Genomics, CarMax, CNH Industrial, Global Payments, Infosys, Huya, JD.com, Oshkosh, Restaurant Brands International and WiPro.
24 days ago
Last Updated: 23 days ago
Monday's top analyst upgrades and downgrades included Carnival, Five9, Knight-Swift, Las Vegas Sands, Norwegian Cruise Line, Paysafe, Warby Parker and Whirlpool.
2 months ago
Last Updated: 2 months ago
Thursday's top analyst upgrades and downgrades included ADT, Chevron, Camping World, Costco, D.R. Horton, General Electric, Nio and Occidental Petroleum.
10 months ago
Last Updated: 10 months ago
Wednesday's top analyst upgrades and downgrades included Applied Materials, Caterpillar, Costco Wholesale, JPMorgan, Spotify, Vertex Pharmaceutical, Vornado Realty Trust and Whiting Petroleum.
1 year ago
Last Updated: 5 months ago
Wednesday's top analyst upgrades and downgrades included Alexion Pharmaceuticals, Amazon.com, Diageo, eBay, Etsy, Home Depot, MGIC Investment, Netflix, Sirius XM and Vir Biotechnology.
1 year ago
Last Updated: 1 year ago
Vir Biotechnology shares jumped on Tuesday after the firm announced that it would be expanding its late-stage COVID-19 study in conjunction with GlaxoSmithKline.
1 year ago
24/7 Wall St. has tracked some health care companies with prospects at crafting a vaccine to deal with this novel coronavirus and where they stand now.
1 year ago
Friday's top analyst calls included Amazon, Adobe, AMD, Apple, BlackRock, Broadcom, Caterpillar, Deere, Microsoft, Morgan Stanley, Oracle and Slack.
1 year ago
Last Updated: 1 year ago